PAVMEDLOGONEW15OCT2018.png
PAVmed to Hold Business Update Conference Call on May 17, 2021
03 mai 2021 09h30 HE | PAVmed Inc.
Company conference call and webcast at 4:30 PM EDT NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated,...
Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
29 avr. 2021 09h30 HE | PAVmed Inc.
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that...
PAVMEDLOGONEW15OCT2018.png
PAVmed to Present at the 20th Annual Needham Healthcare Conference
08 avr. 2021 09h30 HE | PAVmed Inc.
NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today...
PAVMEDLOGONEW15OCT2018.png
PAVmed to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
10 mars 2021 09h30 HE | PAVmed Inc.
On-demand corporate presentation scheduled for March 17, 2021 NEW YORK, March 10, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...
PAVMEDLOGONEW15OCT2018.png
PAVmed Retires Convertible Debt
03 mars 2021 09h30 HE | PAVmed Inc.
NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today...
PAVMEDLOGONEW15OCT2018.png
PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors
01 mars 2021 09h30 HE | PAVmed Inc.
NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today...
PAVMEDLOGONEW15OCT2018.png
PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results
22 févr. 2021 08h18 HE | PAVmed Inc.
Announces majority-owned subsidiary Lucid Diagnostics intends to spin-off into a separate public company Lucid Diagnostics to launch major new multi-channel commercialization initiative for its...
PAVMEDLOGONEW15OCT2018.png
PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST
18 févr. 2021 09h30 HE | PAVmed Inc.
Conference call and live webcast was previously scheduled for 4:30 PM EST Lucid Diagnostics strategic advisor and medical diagnostics pioneer Stanley Lapidus to join call NEW YORK, Feb. 18, 2021 ...
First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed’s CarpX® Device
16 févr. 2021 09h30 HE | PAVmed Inc.
NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today...
PAVMEDLOGONEW15OCT2018.png
PAVmed to Hold Business Update Conference Call on February 22, 2021
09 févr. 2021 09h30 HE | PAVmed Inc.
NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today...